Time to reconsider thromboembolic risk and anticoagulation in transthyretin cardiac amyloidosis?
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2648
Abstract: This article refers to ‘Systemic embolism in amyloid transthyretin cardiomyopathy’ by S. Vilches et al. , pub-lished in Eur J Heart Fail 2022;24: 1 387– 1 396. read more here.
Keywords: time reconsider; transthyretin; thromboembolic risk; anticoagulation transthyretin ... See more keywords